No, you just caused me to stop and think.
biosynthesis ---> sounds cool, but lots of competition. There seems to be a lot of companies who can create synthetic cannibinoids (or combos). Like you said, if it really is a disruptive tech with high yield/low cost, why haven't people come knocking?
bioinformatics ---> i feel like all the big boys have similar systems, but dont bother pumping it because they have quality candidates
Drugs --> a long way away and better IP exists out there already (NMUS) and a bunch of cheap warrants flying around
I took profits when it popped, and will wait and see on IMLFF. I make my own choices, dont worry vinpat!
News 
Market Data 
Discover 
AI
